These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8519256)

  • 1. Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.
    Wyper DJ; Brown D; Patterson J; Owens J; Hunter R; Teasdale E; McCulloch J
    Eur J Nucl Med; 1993 May; 20(5):379-86. PubMed ID: 8519256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease.
    Brown D; Chisholm JA; Owens J; Pimlott S; Patterson J; Wyper D
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):296-300. PubMed ID: 12552349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography.
    Holman BL; Gibson RE; Hill TC; Eckelman WC; Albert M; Reba RC
    JAMA; 1985 Dec; 254(21):3063-6. PubMed ID: 3877181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT.
    Pakrasi S; Colloby SJ; Firbank MJ; Perry EK; Wyper DJ; Owens J; McKeith IG; Williams ED; O'Brien JT
    J Neurol; 2007 Jul; 254(7):907-13. PubMed ID: 17361343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
    J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT.
    Colloby SJ; McKeith IG; Wyper DJ; O'Brien JT; Taylor JP
    J Neurol; 2015 Sep; 262(9):2144-53. PubMed ID: 26122542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls.
    Wyper D; Teasdale E; Patterson J; Montaldi D; Brown D; Hunter R; Graham D; McCulloch J
    Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of cerebral muscarinic receptors with I-123 QNB and SPECT: studies in normal subjects and patients with dementia.
    Weinberger DR; Jones DW; Sunderland T; Lee KS; Sexton R; Gorey J; Reba R
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():194A-195A. PubMed ID: 1498808
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo imaging of muscarinic receptors in the aging female brain with (R,R)[123I]-I-QNB and single photon emission tomography.
    Norbury R; Travis MJ; Erlandsson K; Waddington W; Owens J; Pimlott S; Ell PJ; Murphy DG
    Exp Gerontol; 2005 Mar; 40(3):137-45. PubMed ID: 15763390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic cholinergic receptor binding: in vivo depiction using single photon emission computed tomography and radioiodinated quinuclidinyl benzilate.
    Drayer B; Jaszczak R; Coleman E; Storni A; Greer K; Petry N; Lischko M; Flanagan S
    J Comput Assist Tomogr; 1982 Jun; 6(3):536-43. PubMed ID: 6980235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodo-QNB cortical binding and brain perfusion: effects of a cholinergic basal forebrain lesion in the rat.
    Sorger D; Kämpfer I; Schliebs R; Rossner S; Dannenberg C; Knapp WH
    Nucl Med Biol; 1999 Jan; 26(1):9-16. PubMed ID: 10096495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between blood flow and muscarinic receptor distribution in rat brain after middle cerebral artery occlusion.
    Kuji I; Matsuda H; Sumiya H; Taki J; Tsuji S; Kinuya K; Ichikawa A; Shiba K; Mori H; Tonami N
    Eur J Nucl Med; 1997 Jun; 24(6):665-9. PubMed ID: 9169575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine receptors and cerebral blood flow in partial epilepsy.
    Bartenstein P; Ludolph A; Schober O; Lottes G; Scheidhauer K; Sciuk J; Beer HF
    Eur J Nucl Med; 1991; 18(2):111-8. PubMed ID: 1646108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.
    Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D
    Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons.
    Varastet M; Brouillet E; Chavoix C; Prenant C; Crouzel C; Stulzaft O; Bottlaender M; Cayla J; Mazière B; Mazière M
    Eur J Pharmacol; 1992 Mar; 213(2):275-84. PubMed ID: 1521561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
    Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease.
    Kemp PM; Holmes C; Hoffmann S; Wilkinson S; Zivanovic M; Thom J; Bolt L; Fleming J; Wilkinson DG
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1567-70. PubMed ID: 14617718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease.
    Fukuchi K; Hashikawa K; Seike Y; Moriwaki H; Oku N; Ishida M; Fujita M; Uehara T; Tanabe H; Kusuoka H; Nishimura T
    J Nucl Med; 1997 Mar; 38(3):467-70. PubMed ID: 9074540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.